Total Available Market (TAM)
Total Hip Arthroplasty - THA
The user customer of the ASTI system from Value Forces Ltd is the orthopedic surgeon performing THA procedures. The surgeon is a key decision maker in the selection of THA devices, s/w systems, and prosthesis components. An ancillary but direct customer is the hospital that approves usage of medical devices and provides procurement services. National Health Systems and Health Insurance companies who cover the cost of revision THA are critical participants in the industry. The ultimate beneficiary of the ASTI system is the patient who avoids a revision THA and maintains an active lifestyle after a successful THA procedure.
The target available market comprises the number of THA's performed annually in thirty OECD countries. The group of advanced OECD countries will perform 2.8 million THA surgeries in 2030. Most of these countries have national joint registries that analyze trends and report clinical outcome statistics. Intraoperative periprosthetic femoral fractures and aseptic stem loosening are typically in the top 4 diagnosis of early revision THA surgery (0-90 days).
The ASTI system is aligned with the UN Sustainable Development Goal #3, for good health and well being for people of all ages.
- The number of revision THA’s in 2030 is estimated at 224,000 at a rate of 8%.
The ASTI system is aligned with the UN Sustainable Development Goal #5, to enable gender equality in the specialized field of hip replacement surgery.
- THA is the orthopedic specialty least populated by women. Orthopedics is one of the least gender diverse medical specialties, with the percentage of women at 1% in India, 7% in the USA, and 6% in Europe (according to the European Federation of National Associations of Orthopaedics 2020). A USA survey indicated that only 5% of women orthopedic surgeons specialized in Hip & Knee, with 70% perceiving that too much physical strength is needed. The ASTI system with auto-impaction addresses that concern.
The following chart shows the number of THA surgeries performed in selected countries. Growing from 1.7 million in 2020 to 2.8 million in 2030. These THA volume estimates are based on an OECD report of THA per 100,000 population and the annual growth rate reported in the Journal of Rheumatology.
